
Hyaluronic Acid Market Report 2026
Global Outlook – By Product (Multiple Injection Dose, Single Injection Dose), By Grade (Pharmaceutical Grade Hyaluronic Acid, Cosmetic Grade Hyaluronic Acid), By Source (Microbial Fermentation, Animal Based, Plant Based), By Application (Pharmaceutical Active Pharmaceutical Ingredient, Aesthetics, Osteoarthritis, Cosmetics, Ophthalmology, Dietary Supplements), By End User (Dermatology Clinics, Cosmetic Surgery Centers, Medical Spas And Beauty Centers, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Hyaluronic Acid Market Overview
• Hyaluronic Acid market size has reached to $7.84 billion in 2025 • Expected to grow to $11.93 billion in 2030 at a compound annual growth rate (CAGR) of 8.7% • Growth Driver: Rise In Aesthetic Procedures Fueling The Growth Of The Market Due To Increasing Demand For Minimally Invasive Cosmetic Treatments • Market Trend: Innovations In Cationic Hyaluronic Acid Driving Advanced Skincare Applications • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Hyaluronic Acid Market?
Hyaluronic acid is a naturally occurring substance in the human body, mainly found in the skin, connective tissues, and eyes. It functions as a lubricant and cushion in joints and tissues while also playing a key role in retaining moisture. Because of its strong ability to hold water, it helps keep the skin hydrated, plump, and elastic. It is widely used in skincare products for moisturizing and anti-aging, as well as in medical applications such as joint injections for osteoarthritis, wound healing, and eye surgeries. The main types of products with hyaluronic acid are multiple-injection doses and single-injection doses. A multiple injection dose refers to the administration of a medication through several injections over a period of time to maintain effective therapeutic levels in the body. It includes various grades, such as pharmaceutical-grade hyaluronic acid and cosmetic-grade hyaluronic acid, and is derived from various sources, such as microbial fermentation, animal-based, and plant-based. It finds applications in active pharmaceutical ingredients, aesthetics, osteoarthritis, cosmetics, ophthalmology, and dietary supplements and caters to diverse end users, including dermatology clinics, cosmetic surgery centers, medical spas, beauty centers, and others.
What Is The Hyaluronic Acid Market Size and Share 2026?
The hyaluronic acid market size has grown strongly in recent years. It will grow from $7.84 billion in 2025 to $8.54 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to expansion of cosmetic and dermatology procedures, increased prevalence of osteoarthritis, advances in biopolymer production methods, rising consumer awareness of skincare benefits, growth of minimally invasive treatments.What Is The Hyaluronic Acid Market Growth Forecast?
The hyaluronic acid market size is expected to see strong growth in the next few years. It will grow to $11.93 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing demand for anti-aging solutions, rising adoption of regenerative medicine applications, expansion of pharmaceutical-grade hyaluronic acid usage, growing focus on sustainable sourcing, increasing investments in advanced formulation technologies. Major trends in the forecast period include increasing demand for injectable aesthetic treatments, rising use of hyaluronic acid in osteoarthritis care, growing adoption of microbial fermentation production, expansion of multi-application formulations, enhanced focus on high-purity grades.Global Hyaluronic Acid Market Segmentation
1) By Product: Multiple Injection Dose, Single Injection Dose 2) By Grade: Pharmaceutical Grade Hyaluronic Acid, Cosmetic Grade Hyaluronic Acid 3) By Source: Microbial Fermentation, Animal Based, Plant Based 4) By Application: Pharmaceutical Active Pharmaceutical Ingredient, Aesthetics, Osteoarthritis, Cosmetics, Ophthalmology, Dietary Supplements 5) By End User: Dermatology Clinics, Cosmetic Surgery Centers, Medical Spas And Beauty Centers, Other End Users Subsegments: 1) By Multiple Injection Dose: Pre-Filled Syringes, Vials With Reconstitution Kits, Combination Therapy Formats, Extended-Release Formulations 2) By Single Injection Dose: Pre-Filled Single-Use Syringes, Ampoules, Cartridges, Ready-To-Inject PensWhat Is The Driver Of The Hyaluronic Acid Market?
The rise in the number of aesthetic procedures is expected to propel the growth of the hyaluronic acid market going forward. Aesthetic procedures refer to treatments and interventions aimed at improving appearance, enhancing features, and rejuvenating the skin or body to achieve a more youthful and harmonious look. The number of aesthetic procedures is rising as technological advancements have made treatments safer, less invasive, and more effective, encouraging more people to undergo them. Hyaluronic acid is useful in aesthetic procedures, as it helps restore facial volume, reduce wrinkles, and enhance skin hydration for a smoother and more youthful look. For instance, in June 2025, according to the American Society of Plastic Surgeons, a US-based Plastic Surgery Foundation, in 2024, over 800,000 aesthetic patients used these procedures to support their health goals, with tummy tucks holding the second spot in popularity and showing a 1% rise from 2023, while facelifts and forehead lifts each recorded a 1% increase as well. Therefore, the rise in the number of aesthetic procedures is driving the growth of the hyaluronic acid industry.Key Players In The Global Hyaluronic Acid Market
Major companies operating in the hyaluronic acid market are AbbVie Inc., L'Oréal S.A., LG Chem Ltd., Shiseido Company Limited, Givaudan SA, Zimmer Biomet Holdings Inc., Grifols S.A., Smith & Nephew plc, Kikkoman Biochemifa Company Ltd., Galderma S.A., Kewpie Corporation, Merz Pharma GmbH & Co. KGaA, Fidia Farmaceutici S.p.A., Anika Therapeutics Inc., Lifecore Biomedical Inc., Croma-Pharma GmbH, Contipro a.s., Seikagaku Corporation, HTL Biotechnology SAS, Altergon Italia S.r.l., Bloomage Biotechnology Corporation Limited.Global Hyaluronic Acid Market Trends and Insights
Major companies operating in the hyaluronic acid market are focusing on developing innovative products, such as novel cationic hyaluronic acid, to enhance skin adhesion, boost hydration performance, and expand applications in rinse-off formulations. Novel cationic hyaluronic acid refers to a positively charged, chemically modified form of hyaluronic acid designed to enhance adhesion, cellular interaction, and stability for advanced medical and cosmetic applications. For instance, in March 2023, Givaudan S.A., a Switzerland-based chemicals company, launched PrimalHyal Hydra, a novel cationic hyaluronic acid crafted by white biotechnology that sets a new gold standard for skin hydration. This innovative active ingredient provides instant hydration after just one application and sustains moisturization for up to four days, outperforming standard hyaluronic acid by at least a factor of two. It works effectively in both rinse-off and leave-on cosmetic formulations and also reinforces the skin barrier by boosting lipid and protein production. The ingredient is clinically tested and designed for broad application across skincare categories, including lotions, shower gels, and masks, offering long-lasting hydration and skin barrier benefits with enhanced skin adhesion properties.What Are Latest Mergers And Acquisitions In The Hyaluronic Acid Market?
In July 2025, Waldencast plc, a UK-based beauty and wellness company, acquired Novaestiq Corp. for an undisclosed amount. With this acquisition, Waldencast aims to strategically expand Obagi Medical's product portfolio beyond medical-grade skincare into the rapidly growing U.S. dermal filler market, effectively doubling its addressable market and positioning Obagi Medical as a leader in integrated skincare and aesthetic solutions to drive significant growth and innovation in the aesthetics industry. Novaestiq Corp. is a US-based company that develops and commercializes aesthetic and dermatological products, particularly hyaluronic acid dermal fillers.Regional Insights
North America was the largest region in the hyaluronic acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Hyaluronic Acid Market?
The hyaluronic acid market consists of sales of hyaluronic acid serums, moisturizers, facial masks, dermal fillers, viscosupplements, burn and ulcer treatments, and eye drops. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Hyaluronic Acid Market Report 2026?
The hyaluronic acid market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hyaluronic acid industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Hyaluronic Acid Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $8.54 billion |
| Revenue Forecast In 2035 | $11.93 billion |
| Growth Rate | CAGR of 9.0% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Grade, Source, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | AbbVie Inc., L'Oréal S.A., LG Chem Ltd., Shiseido Company Limited, Givaudan SA, Zimmer Biomet Holdings Inc., Grifols S.A., Smith & Nephew plc, Kikkoman Biochemifa Company Ltd., Galderma S.A., Kewpie Corporation, Merz Pharma GmbH & Co. KGaA, Fidia Farmaceutici S.p.A., Anika Therapeutics Inc., Lifecore Biomedical Inc., Croma-Pharma GmbH, Contipro a.s., Seikagaku Corporation, HTL Biotechnology SAS, Altergon Italia S.r.l., Bloomage Biotechnology Corporation Limited. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
